Pathway Therapeutics
Latest round
- Series A
Last raised
- May 2011
Total raised
- $24M
Investors
- 5
About Pathway Therapeutics
Pathway Therapeutics Inc.Pathway Therapeutics Inc. is engaged in the development of advanced healthcare technology solutions. Founded in 2008 and headquartered in San Francisco, US, the company has undergone significant developments in its business strategy.40 mn.PathwayTX specializes in developing innovative technology solutions designed to enhance the efficiency and effectiveness of healthcare delivery. The company's core product offerings include a comprehensive digital health platform that integrates clinical data management, patient engagement tools, and analytics capabilities. These solutions aim to streamline workflows for healthcare providers while improving patient outcomes through more personalized care. PathwayTX caters primarily to healthcare institutions, including hospitals, clinics, and private practices, facilitating better coordination of care among providers and patients.PathwayTX generates revenue through a B2B transaction structure, primarily involving subscription-based models for their digital health platform. Clients typically engage in annual agreements that provide them access to the full suite of features, including data analytics and patient management tools. The pricing plans are tiered based on the size of the healthcare institution and the specific features utilized, ensuring that organizations can select an option that best fits their needs. Flagship products within their offerings feature capabilities that allow for customizable interfaces and integration with existing healthcare systems, enhancing the overall user experience.Pathway Therapeutics Inc. The company is developing new features for its digital health platform, aiming for a release by the end of 2024. Additionally, it targets expansion into additional European markets and the Asia-Pacific region by 2025.
Who invested in Pathway Therapeutics
5 investors across 4 rounds
See all investors in Pathway Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pathway Therapeutics
Who invested in Pathway Therapeutics?
Pathway Therapeutics has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pathway Therapeutics raised?
Pathway Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Pathway Therapeutics last raise money?
Pathway Therapeutics's most recent round on record is a Series A, in May 2011.
What does Pathway Therapeutics do?
Pathway Therapeutics is a pharmaceuticals company.
Where is Pathway Therapeutics headquartered?
Pathway Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Pathway Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Pathway Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Pathway Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.